Editorial Commentary: Critically Ill Patients With Clostridium difficile Infection: Are 2 Antibiotics Better Than One?

about

The Uncertain Benefits of Combination Therapy for Clostridium difficile Infection.

P2860

Q54697058-2F75F264-C43A-4C6C-890D-BCEAD1B4AA2F

P2860

Editorial Commentary: Critically Ill Patients With Clostridium difficile Infection: Are 2 Antibiotics Better Than One?

Item

http://www.wikidata.org/entity/Q52836854

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Editorial Commentary: Critical ...... 2 Antibiotics Better Than One?

@en

Editorial Commentary: Critical ...... 2 Antibiotics Better Than One?

@nl

type

Item

label

Editorial Commentary: Critical ...... 2 Antibiotics Better Than One?

@en

Editorial Commentary: Critical ...... 2 Antibiotics Better Than One?

@nl

prefLabel

Editorial Commentary: Critical ...... 2 Antibiotics Better Than One?

@en

Editorial Commentary: Critical ...... 2 Antibiotics Better Than One?

@nl

P1154

2-s2.0-84940643335

http://www.w3.org/2001/XMLSchema#string

P1433

Clinical Infectious Diseases

P1476

Editorial Commentary: Critical ...... 2 Antibiotics Better Than One?

@en

P2860

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients

Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.

Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection.

Combination therapy for treatment of infections with gram-negative bacteria.

Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease

Outcome of ICU patients with Clostridium difficile infection.

Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection

A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.

P304

942-944

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/CID/CIV413

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mark H. Wilcox

P5530

4161849

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1031294794

http://www.w3.org/2001/XMLSchema#string

P698

26024908

http://www.w3.org/2001/XMLSchema#string

P921

antibiotic

Clostridium difficile